You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 71 No. 1, January 1964 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Chemotherapy of Experimental Toxoplasmosis

Evaluation of Spiramycin Alone and in Combination

CONRAD L. GILES, MD; LEON JACOBS, PhD; MARJORIE L. MELTON, BA

Arch Ophthalmol. 1964;71(1):119-127.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Introduction

A new antibiotic, spiramycin, isolated from Streptomyces ambofaciens found in soil from the north of France was shown by Garin and Eyles1 to be effective in the treatment of experimentally induced murine toxoplasmosis. This finding prompted Chodos and Habegger-Chodos to use the drug in a series of 67 patients in this country in 1961.2 They concluded that spiramycin was an effective agent for use in posterior uveitis presumably caused by Toxoplasma and suggested that it replace pyrimethamine and sulfadiazine as the treatment of choice in posterior uveitis. Fajardo, Furgiuele, and Leopold,3 however, reported a series of 87 patients who had received either spiramycin and steroids, sulfadiazine, pyrimethamine (Daraprim) and steroids, or steroid therapy alone, including in this report many of the cases treated by Chodos and Habegger-Chodos and found that, although spiramycin therapy resulted in quiescence of the posterior uveitis, sulfadiazine and pyrimethamine appeared much more . . . [Full Text PDF of this Article]


Author Affiliations

Detroit, Mich; Bethesda, Md

From the Ophthalmology Branch, National Institute of Neurological Diseases and Blindness, and the Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Public Health Service, United States Department of Health, Education and Welfare.


Footnotes

Submitted for publication July 8, 1963.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1964 American Medical Association. All Rights Reserved.